SCHEMBL7249241

SCHEMBL7249241

CCOC(=O)c1sc(SCc2ccccc2)c2c1CCc1cnn(C)c1-2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.62
CCNC P24863 2/20 0.52
CDK8 P49336 2/20 0.52
CDK19 Q9BWU1 2/20 0.52
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CDC7 O00311 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
DBF4 Q9UBU7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7064675 0.87 CCNC (0.53) ADORA2ACCNCCDK8CDK19DRD2
SCHEMBL7244853 0.86 CCNC (0.56) ADORA2ACCNCCDK8CDK19DRD2
SCHEMBL7063434 0.85 CCNC (0.71) ADORA2ACCNCCDK8CDK19DRD2
SCHEMBL7249311 0.84 CCNC (0.54) ADORA2ACCNCCDK8CDK19DRD2
SCHEMBL7041432 0.84 CCNC (0.46) ADORA2ACCNCCDK8CDK19DRD2
SCHEMBL7243399 0.82 CCNC (0.50) ADORA2ACCNCCDK8CDK19DRD2
SCHEMBL7096219 0.82 CCNC (0.56) ADORA2ACCNCCDK8CDK19DRD2
SCHEMBL7243829 0.82 CCNC (0.56) CCNCCDK8CDK19DRD2DRD4
SCHEMBL7242256 0.81 CCNC (0.58) ADORA2ACCNCCDK8CDK19DRD2
SCHEMBL7246960 0.80 CCNC (0.52) ADORA2ACCNCCDK8CDK19DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TST, STS, AHR ADORA2A 1243/4885CCNC 2012/4885CDK8 3614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.